Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

US Patent 10463667 · Granted Nov 5, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aminopyrazine derivatives as PI3K-γ inhibitors2025
Aminopyrazine diol compounds as PI3K-y inhibitors2025
Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors2024
Heterocyclic derivatives as PI3K inhibitors2024
Spirocyclic lactams as JAK2 V617F inhibitors2024
Pyridine and pyridimine compounds as PI3K-gamma inhibitors2024
Aminopyrazine diol compounds as PI3K-γ inhibitors2024
Tertiary alcohols as PI3K-γ inhibitors2024
Heterocyclic compounds as PI3K-γ inhibitors2023
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as 2023
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as 2023
Naphthyridinone compounds as JAK2 V617F inhibitors2023